Positron emission tomography-computed tomography adds to the management of salivary gland malignancies

Laryngoscope

Volumn 120, Issue 4, 2010, Pages 734-738

  Razfar, Ali ^a   Heron, Dwight E ^a   Branstetter IV, Barton F ^a   Seethala, Raja R ^a,b   Ferris, Robert L ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Positron emission tomography computed tomography; Salivary gland tumors

Indexed keywords

ANTINEOPLASTIC AGENT; IOVERSOL;

ACINAR CELL CARCINOMA; ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PALLIATIVE THERAPY; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; INCIDENTAL FINDING; KIDNEY CARCINOMA; LARGE CELL CARCINOMA; LIVER METASTASIS; LUNG ADENOCARCINOMA; LUNG METASTASIS; LYMPH NODE METASTASIS; LYMPHOEPITHELIOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PARATHYROID ADENOMA; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RECURRENT CANCER; RETROSPECTIVE STUDY; SALIVARY GLAND CANCER; SECOND CANCER; SQUAMOUS CELL CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROIDITIS; UNDIFFERENTIATED CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SALIVARY GLAND NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 77950796204     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20829     Document Type: Article

References (11)

1. Terhaard CH, Lubsen H, Van der Tweel I, et al. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Head Neck 2004;26:681-692; discussion 692-693. (Pubitemid 39014632)
2. Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2, 807 patients. Head Neck Surg 1986;8: 177-184.
3. Ozawa H, Tomita T, Sakamoto K, et al. Mucoepidermoid carcinoma of the head and neck: clinical analysis of 43 patients. Jpn J Clin Oncol 2008;38:414-418. (Pubitemid 351965945)
4. Zimmer LA, Branstetter BF, Nayak JV, et al. Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck. Laryngoscope 2005;115:2029-2034.
5. Branstetter BF, Blodgett TM, Zimmer LA, et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 2005;235:580-586.
6. Agarwal V, Branstetter BF, Johnson JT. Indications for PET/CT in the head and neck. Otolaryngol Clin North Am 2008;41:23-49, v. (Pubitemid 351186576)
7. Roh JL, Ryu CH, Choi SH, et al. Clinical utility of 18FFDG PET for patients with salivary gland malignancies. J Nucl Med 2007;48:240-246.
8. Jeong HS, Chung MK, Son YI, et al. Role of 18F-FDG PET/CT in management of high-grade salivary gland malignancies. J Nucl Med 2007;48:1237-1244.
9. Basu D, Siegel BA, McDonald DJ, et al. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18. Arch Otolaryngol Head Neck Surg 2007;133:801-805. (Pubitemid 47295762)
10. Ha PK, Hdeib A, Goldenberg D, et al. The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2006;132:12-16. (Pubitemid 43127956)
11. Fleming AJ Jr, Smith SP Jr, Paul CM, et al. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients. Laryngoscope 2007;117:1173-1179. (Pubitemid 47015665)